These side effects were notably milder when compared with an inhibitor of both equally bromodomains. A detailed molecular Evaluation also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor - "Our study uncovered the crucial position from the KLF16/MYC regulatory axis in modulating tumor https://abbv-744forsmallcelllungc13579.techionblog.com/32074823/abbv-744-in-combination-with-immunotherapy-an-overview